Point Clare Chiropractic
www.pointclarechiropractic.com.au
​
PH: 02 4322 0199
  • Home
  • Services
  • What is Chiropractic?
  • The Biophysics Difference
  • About Dr Holland
  • Bookings & Contact
  • Hot Topics Blog

Chiropractic and Migraines, adverse events

6/19/2017

0 Comments

 
The benefits of Chiropractic on Migraine Headaches have long been known and reported but I came across an interesting article in:

Journal of Musculoskeletal Science and Practice

Title - Adverse events in a chiropractic spinal manipulative therapy single-
blinded, placebo, randomized controlled trial for migraineurs
Volume 29, June 2017, Pages 66–71

The researchers in this paper have looked at adverse events from manipulation for Migraine Headaches.  700 subjects were sorted into two groups, 355 receiving placebo and 355 receiving manipulation.

The results: Local tenderness was the most common AE, reported by 11.3% and 6.9% of the CSMT group and the placebo group, respectively, and tiredness on the intervention day was reported by 8.5% and 1.4% of CSMT group and the placebo group, respectively.

There were no serious adverse events at all.

This research adds to the growing body of research on the safety of Chiropractic treatment for conditions such as migraine headaches, the medications for which often have numerous side effects.

0 Comments

Chondroitin vs Celecoxib for Knee Osteoarthritis

6/5/2017

0 Comments

 
An interesting article surfaced last week regarding Chondroitin in medical news.

High-quality chondroitin sulfate is as effective as celecoxib in treating knee osteoarthritis, according to an international trial in the Annals of the Rheumatic Diseases.

Roughly 600 adults over 50 with primary knee osteoarthritis were randomized to receive pharmaceutical-grade chondroitin sulfate (800 mg) plus placebo, celecoxib (200 mg) plus placebo, or double placebo daily for 6 months.

At the conclusion of the trial, the chondroitin and celecoxib groups had significantly greater reductions in pain relative to the placebo group, with no difference between the two active treatments.

At 3 and 6 months, chondroitin and celecoxib conferred significant improvements in function relative to placebo, with no difference between the two active groups.

Noting the risks associated with long-term use of NSAIDs and acetaminophen, he authors suggest chondroitin sulfate "should be considered a first-line treatment in the medical management of knee OA."

This is promising news following the recent discovery that arthroscopes for osteoarthritis of the knee has no clinical relevance.
Picture
0 Comments

    About

    Blog by Dr Kieron Holland and Point Clare Chiropractic.

    Archives

    August 2019
    June 2019
    May 2019
    April 2019
    March 2019
    November 2018
    February 2018
    October 2017
    September 2017
    July 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    March 2016
    February 2016
    October 2015
    September 2015

    Categories

    All

    RSS Feed

Location

Contact Us 

4322 0199